F. Buonfiglioli
YOU?
Author Swipe
View article: Impact of contrast dye submucosal pre-lifting on cold snare resection of small polyps: an Italian randomized observational trial
Impact of contrast dye submucosal pre-lifting on cold snare resection of small polyps: an Italian randomized observational trial Open
Background/Aims: Small polyps are the most frequently detected lesions during colonoscopy, with an incomplete resection rate of 6.8% to 15.9%. This study aimed to improve small polyp cold snare resection radicality using submucosal contras…
View article: Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD)
Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD) Open
View article: The Gastropack Access System as a Model to Access Gastroenterology Services for Gastroscopy Appropriateness in Patients with Upper Gastrointestinal Symptoms: A Comparison with the Open Access System
The Gastropack Access System as a Model to Access Gastroenterology Services for Gastroscopy Appropriateness in Patients with Upper Gastrointestinal Symptoms: A Comparison with the Open Access System Open
Esophagogastroduodenoscopy (EGD) appropriateness in Open-Access System (OAS) is a relevant issue. The Gastropack Access System (GAS) is a new system to access gastroenterological services, based on the partnership between Gastroenterologis…
View article: Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals Open
View article: Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals Open
View article: Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals Open
View article: Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum Open
Direct antiviral therapy has dramatically changed our possibility to eradicate hepatitis C virus (HCV) infection in all stages of chronic liver disease, with sustained virological response rates well above 90%. HCV eradication should lead …
View article: Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis Open
View article: Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens Open
View article: Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients Open
View article: Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens
Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens Open
View article: Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients Open
View article: Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older
Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older Open
Summary The availability of direct‐acting antiviral agents ( DAA ) regimens has expanded the pool of patients eligible for treatment. However, data on the virologic response and tolerability of DAA s in elderly patients are lacking. We eva…
View article: Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals Open
View article: Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study Open
View article: Relationship between indocyanine green retention test, decompensation and survival in patients with Child‐Pugh A cirrhosis and portal hypertension
Relationship between indocyanine green retention test, decompensation and survival in patients with Child‐Pugh A cirrhosis and portal hypertension Open
Background & Aims Indocyanine green retention test (ICG‐r15) is a non‐invasive marker of functional hepatic reserve. Among patients with compensated cirrhosis, ICG‐r15 correlates to the degree of portal hypertension (PH); however, its prog…
View article: Development of Hepatocellular Carcinoma in HCV Cirrhotic Patients Treated with Direct Acting Antivirals
Development of Hepatocellular Carcinoma in HCV Cirrhotic Patients Treated with Direct Acting Antivirals Open